PDCD1 and neoplasm: This was verified in mice with progressive liver metastatic disease; the PD-1 antibody provoked a limited response, but in combination with TGF-β inhibition, a robust and enduring cytotoxic T-cell response against tumor cells occurred, preventing metastasis [162].